SomnoMed Ltd (ASX: SOM) Share Price and News

Price

$0.63

Movement

0.01 (+1.61%)

as at 6 Jun - Closed (20 mins delayed)

52 Week Range

$0.22 - $0.695

 
1 Year Return

+142.31%

SomnoMed Ltd Chart and Price Data

2025
2025
2025
2025
$0.25
$0.50
$0.75
$0.25
$0.50
$0.75
$0.25
$0.50
$0.75
$0.25
$0.50
$0.75

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $136.15 million
P/E Ratio 136.99
Dividend Yield 0.00%
Shares Outstanding 216.11 million
Earnings per share -0.049
Dividend per share N/A
Year To Date Return 34.78%
Earnings Yield 0.73%
Franking -
Share Price

$0.63

Day Change

0.01 (+1.61%)

52 Week Range

$0.22 - $0.695

Yesterday's Close

$0.62

Today's Open

$0.615

Days Range

$0.56 - $0.63

Volume

43,740

Avg. Volume (1 month)

60,580

Turnover

$26,937

as at 6 Jun - Closed

  • SomnoMed Ltd (ASX: SOM)
    Latest News

    a woman
    Investing

    8 shares you need to watch on Tuesday

    The Coca-Cola Amatil (ASX:CCL) share price could receive some unwanted attention again today

    Read more »

    a woman
    Investing

    Why the Somnomed Limited share price surged 11% today

    The Somnomed (ASX:SOM) share price hit a 52-week low on Friday

    Read more »

    a woman
    Investing

    Why these 4 ASX shares have started the week with solid gains

    The Iluka Resources Limited (ASX:ILU) share price is one of four starting the week with solid gains. Here’s why…

    Read more »

    a woman
    Investing

    Why these 4 ASX shares have climbed higher today

    The Bellamy's Australia Ltd (ASX:BAL) share price is one of four defying the market and climbing higher today. Here’s why…

    Read more »

    a woman
    Investing

    Why these 4 ASX shares have sunk like stones today

    The Santos Ltd (ASX:STO) share price is one of four sinking like stones today. Here’s why…

    Read more »

    a woman
    Investing

    S&P/ASX 200 finishes higher Wednesday: 9 shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) ended higher on Wednesday with share price gains from a2 Milk Company Ltd (Australia) (ASX:A2M) and…

    Read more »

    a woman
    Investing

    Why the Somnomed Limited share price is cratering today

    Could Nanosonics Ltd (ASX:NAN) be a better bet than Somnomed Limited (ASX:SOM)?

    Read more »

    a woman
    Investing

    Why Somnomed Limited is among 4 shares falling today

    The market is rallying strongly today, but that hasn't been enough to help shares like Somnomed Limited (ASX:SOM).

    Read more »

    a woman
    Investing

    Why MesoBLAST limited is rocketing higher on FDA approval

    The Mesoblast limited (ASX:MSB) share price is responding to FDA recognition of its aGVHD drug.

    Read more »

    a woman
    Investing

    Why these 4 shares are soaring higher today

    These four shares have started the week off on a very positive note.

    Read more »

    a woman
    Investing

    ASX 200 slammed: 12 shares you should have been watching

    The gold miners glistered on a day to forget for the ASX

    Read more »

    a woman
    Investing

    Is ResMed Inc. (CHESS) the best new software company on the ASX?

    ResMed Inc. (CHESS) (ASX:RMD) could tick the boxes for tech and healthcare investors.

    Read more »

    SOM ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    30th Apr 2025 2025-04-30T14:54:44 Quarterly Cashflow ReportYesNo2:54pm5773k
    30th Apr 2025 2025-04-30T14:53:59 Quarterly Activities ReportYesNo2:53pm2312k
    7th Apr 2025 2025-04-07T15:22:56 United States of America tariff updateYesNo3:22pm1237k
    28th Feb 2025 2025-02-28T08:48:33 Investor presentationYesNo8:48am191.1M
    28th Feb 2025 2025-02-28T08:47:57 FY25 Half Year ResultsYesNo8:47am3189k
    28th Feb 2025 2025-02-28T08:41:07 Half Yearly Report and AccountsYesNo8:41am184.7M
    11th Feb 2025 2025-02-11T09:01:01 H1FY25 Financial Results webinar detailsYesNo9:01am1147k
    29th Jan 2025 2025-01-29T18:53:58 Notification regarding unquoted securities - SOMYesNo6:53pm719k
    24th Jan 2025 2025-01-24T08:44:52 Quarterly Appendix 4C Cash Flow ReportYesNo8:44am5777k
    24th Jan 2025 2025-01-24T08:44:32 FY25 Guidance Update and Quarterly ReportYesNo8:44am2165k

    About SomnoMed Ltd

    SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, SomTabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the onlyreportable segment. Substantial revenue is realized from the European region.

    SOM Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    06 Jun 2025 $0.63 $0.01 1.61% 43,740 $0.62 $0.63 $0.56
    05 Jun 2025 $0.62 $-0.02 -3.15% 7,233 $0.64 $0.64 $0.62
    04 Jun 2025 $0.64 $0.05 8.47% 29,650 $0.59 $0.64 $0.59
    03 Jun 2025 $0.59 $-0.01 -1.67% 40,518 $0.59 $0.60 $0.59
    02 Jun 2025 $0.60 $0.03 5.24% 116,817 $0.55 $0.60 $0.55
    29 May 2025 $0.57 $-0.02 -3.36% 1,381 $0.56 $0.57 $0.56
    28 May 2025 $0.60 $0.01 1.71% 59,938 $0.56 $0.60 $0.53
    27 May 2025 $0.59 $0.02 3.54% 144,023 $0.56 $0.60 $0.55
    26 May 2025 $0.57 $-0.01 -1.74% 1,881 $0.57 $0.59 $0.57
    23 May 2025 $0.58 $0.02 3.64% 9,789 $0.55 $0.58 $0.52
    22 May 2025 $0.55 $-0.05 -8.33% 63,667 $0.58 $0.58 $0.55
    21 May 2025 $0.60 $0.06 11.11% 6,653 $0.54 $0.60 $0.54
    20 May 2025 $0.54 $-0.03 -5.26% 14,019 $0.57 $0.57 $0.52
    19 May 2025 $0.57 $0.03 5.56% 39,816 $0.57 $0.57 $0.56
    16 May 2025 $0.54 $0.02 3.85% 28,882 $0.52 $0.55 $0.52
    15 May 2025 $0.52 $0.01 1.96% 148,627 $0.48 $0.52 $0.48
    14 May 2025 $0.51 $-0.01 -1.92% 9,958 $0.51 $0.52 $0.50
    13 May 2025 $0.52 $0.02 4.00% 63,933 $0.49 $0.52 $0.49
    12 May 2025 $0.50 $0.03 6.32% 31,000 $0.48 $0.50 $0.48
    09 May 2025 $0.48 $0.00 0.00% 131,201 $0.48 $0.48 $0.48
    08 May 2025 $0.48 $-0.01 -2.08% 111,233 $0.48 $0.53 $0.47

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    05 Dec 2024 Michael Gordon Issued 500,000 $227,500
    Issue of options.
    05 Dec 2024 Gaetano (Guy) Russo Buy 665,000 $294,661
    On-market trade.
    05 Dec 2024 Gaetano (Guy) Russo Issued 700,000 $318,500
    Issue of options.
    05 Dec 2024 Benjamin(Ben) Gisz Issued 300,000 $136,500
    Issue of options.
    23 Sep 2024 Karen Borg Buy 12,238 $5,384
    On-market trade. share approximately
    09 Sep 2024 Karen Borg Buy 25,593 $10,749
    On-market trade. share approximately
    01 Jul 2024 Karen Borg Issued 575,000 $155,250
    Issue of options.
    01 Jul 2024 Amrita Blickstead Issued 575,000 $155,250
    Issue of options.
    28 Jun 2024 Karen Borg Issued 750,000 $189,375
    Issue of options.
    28 Jun 2024 Amrita Blickstead Issued 750,000 $189,375
    Issue of options.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Michael Gordon Non-Executive Director Aug 2020
    Mr Gordon is a Director of K Sleep Holdings Pty Limited (Koala), a direct-to-consumer household goods retailer. Michael was previously the CFO of Rokt, a marketing technology company and CFO of Different Technologies, a property technology company. He started his career with PricewaterhouseCoopers spending 10 years with them in South Africa, the United Kingdom and Australia specialising in the retail and pharmaceutical industries with experience in audit, taxation, and corporate finance. He is also Chair of Risk Committee.
    Mr Gaetano (Guy) Alfred Gerrard Russo Non-Executive ChairmanNon-Executive Director Aug 2020
    Mr Russo has commercial and customer-focussed background working in Australia and internationally. Previously, Guy has served as CEO, Wesfarmers Department Store Division (Kmart & Target); Managing Director, Kmart Australia & NZ; President, McDonald's Greater China; CEO McDonald's Australia Ltd and Chairman of Ronald McDonald House Children's Charities. He is member of the Risk Committee.
    Mr Andrew Price Non-Executive Director Jan 2025
    Mr Price is an executive in the medical device industry, has spent the last 25 years at ResMed in various senior roles. Prior to finishing his employment with ResMed, Andrew was Chief Supply Chain Officer. Andrew held roles at ResMed across product development, project management and business development globally.
    Mr Benjamin(Ben) Gisz Non-Executive Director Oct 2024
    --
    Ms Amrita Blickstead Executive DirectorJoint CEO Feb 2024
    Ms Blickstead has strategic, sales and marketing, and product development expertise. She has experience in retail, ecommerce, medical devices and has been an advocate for diversity & inclusion. Amrita is the former Chief Operating and Marketing Officer at eBay Australia & New Zealand and over her 10-year tenure led many different areas of the business across Strategy, Operations, Marketing, Sales, Loyalty, Advertising, Pricing, Consumer Selling, Cross Border Trade, Shipping and Small & Medium Business. Prior to eBay, Amrita established her career as a Management Consultant at Port Jackson Partners, and a Biomedical Engineer at Ventracor and Cochlear.
    Ms Karen Borg Executive DirectorJoint CEO Feb 2024
    Ms Borg has held senior roles in FTSE 100-250 medical device, technology, consumer products and government services organisations. Karen was most recently the Chief Executive Officer for Catholic Healthcare Ltd and prior to this was the CEO of Healthdirect and the inaugural CEO of Jobs for NSW. Karen began her career in the fast-moving consumer goods sector and worked for Goodman Fielder, Nestle and Revlon in global business development and marketing.
    Mr Terence Anthony Flitcroft Company Secretary
    -
    Darren Collins CFO
    -
    Terence Anthony Flitcroft Company Secretary
    -
    Mark Harding Vice President - Global Marketing
    -
    Van Kleef Vice President - Marketing and Sales Europe
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hsbc Custody Nominees (Australia) Limited 79,932,576 36.99%
    National Nominees Limited 33,745,623 15.62%
    Dottie Investments Pty Ltd 9,166,619 4.24%
    Mutual Trust Pty Ltd 7,746,054 3.58%
    Howarth PAF Pty Ltd <The Howarth Foundation A/C> 5,415,675 2.51%
    J P Morgan Nominees Australian Pty Limited 4,822,719 2.23%
    Equity Plan Services Pty Ltd 4,582,482 2.12%
    BNP Paribas Nominees Pty Ltd <ACF Clearstream A/C> 4,014,796 1.86%
    Caroline House Superannuation Fund Pty Ltd 3,000,000 1.39%
    Timbina Pty Ltd <Timbina Super Fund A/C> 2,696,297 1.25%
    Ginga Pty Ltd 2,169,045 1.00%
    P Neustadt Holdings Pty Ltd <Belgove Super Fund A/C> 2,153,628 1.00%
    Belgove Pty Ltd 2,053,265 0.95%
    Ginga Pty Ltd <TG Klinger Super Fund A/C> 2,000,000 0.92%
    Golden Words Pty Ltd 1,947,082 0.90%
    Mr Nicholas Dermott McDonald 1,706,000 0.79%
    Mr Gaetano Alfred Gerrard Russo & Ms Deanne Maree Bevan 1,390,220 0.64%
    REM Medical Pty Ltd <Cocoon Super Fund A/C> 1,342,801 0.62%
    Howarth PAF Pty Ltd <Howarth Charitable Fund A/C> 1,315,225 0.61%
    Dinwoodie Investments Pty Ltd 1,257,004 0.58%

    Profile

    since

    Note